OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: TITANIUM DIOXIDE 4.7%, OCTINOXATE 2.2%
ACTIVE INGREDIENTS: TITANIUM DIOXIDE 4.7%, OCTINOXATE 2.2%
WARNING: KEEP OUT OF EYES. IF IRRITATION PERSISTS, CONSULT A HEALTH CARE PRACTITIONER. KEEP OUT OF REACH OF CHILDREN.
DIRECTIONS: APPLY PRIOR TO SUN EXPOSURE
PRINCIPAL DISPLAY PANEL
LA MER
THE TREATMENT FLUID FOUNDATION
SPF 15
1.0 FL OZ/30 mL
MAX HUBER RESEARCH LAB INC.
NEW YORK, NY 10022
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 65966-001-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-70bd-f424-e053-dadaa90a57ce | 2661709d-74d5-4a21-8919-a087404c7423 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65966-001-01 | LA MER THE TREATMENT FLUID FOUNDATIONSPF 15 | 1 in 1 CARTON | LIQUID | 1 | 1 | |
| 65966-001-02 | LA MER THE TREATMENT FLUID FOUNDATIONSPF 15 | 30 mL in 1 TUBE | LIQUID | 30 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 65966-001 | 65966-001-02, 65966-001-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TITANIUM DIOXIDE | 15FIX9V2JP | ACTIB |
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| edabc2ce-e1c0-4db5-9d14-46294e20d231 | 2661709d-74d5-4a21-8919-a087404c7423 | 2010-04-02 | Warnings | edabc2ce-e1c0-4db5-9d14-46294e20d231 2661709d-74d5-4a21-8919-a087404c7423 |
Adverse event summaries are temporarily unavailable. Other product information remains available.